ERCP术后相关并发症的分析与防治(3)
[6] F ree ma M. Preve nti on of post- ER CP pa ncrea titis；Ph ar m acol og i c s oluti on or pati e nt s el ecti on and pa ncrea ti c st e nts ?. G ast roe ntero l ogy,2003,124：1977-1980.
[7] Singh P， Das A， Isenberg G， et al. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acutepancreatitis ? A meta-analysis of controlled trials. Gastrointest Endosc，2004，60(4):544-550.
[9] Arvanitidis D， Anagnostopoulos GK， Giannopoulos D， et al. Can somatostatin prevent post-ERCP pancreatitis ? Results of a randomized controlled trial. J Gastroenterol Hepatol，2004，19(3):278-282.
, http://www.100md.com
[9] Masci E，Cavallini G， Mariani A. Comparison of two dosing regimens of gabexate in the prophylaxis of post-ERCP pancreatitis. Am J Gastroenterol，2003，98(10):2182-2186.
[10] 宋丽亚， 赵清喜， 孔心涓， 等. ENBD 预防胆管多发结石ERCP 术后急性胰腺炎及高淀粉酶血症65例. 世界华人消化杂志， 2010，18(16):1724-1727.
[11] Das A，Singh P，Sivak MV JR，et al. Pancreatic-stent placement for prevention of post-ERCP pancreatitis:a cost-effectiveness analysis. Gastrointest Endosc，2007，65(7):960-968.
, http://www.100md.com
[12] Cennamo V，Fuccio L，Zagari RM，et al. Can early precut implementation reduce endoscopic retrograde cholangiopancreatography-related complication risk ? Meta-analysis of randomized controlled trials. Endoscopy， 2010，42(5):381-388.
[13] Petrov MS，Savides TJ. Systematic review of endoscopic ultra-sonography versus endoscopic retrograde cholangiopancreatography for suspected choledocholithiasis. Br J Surg， 2009，96(9):967-974.
[14] 马洪， 肖丽达， 张广俊， 等. 超声引导内镜在梗阻性黄疸诊治中的应用研究. 广西医科大学学报，2010，27(3):397-399.
, http://www.100md.com
[15] N i e dera u C，Po hl ma nn U,L u bke H,et a l. Prop hy l ac tica nti bi o ti c treat me nt i n t herape uti c or co mp li ca t e d di a gnostic ER CP；re sults o f a ra ndo mi ze d contr o ll e d cli ni ca l stu dy. G a st rpo mtest E ndosc，1994,40：533-537.
[16] 胡冰,周岱云,龚彪.ERCP临床诊疗图解.上海:上海科学技术出版社,2004,90:239-246.
[17] Oh HC， Lee SK， Lee TY， et al. Analysis of percutaneous transhepatic cholangioscopy related complications and the risk factors for those complications. Endoscopy， 2007， 39(8):731- 736.
[18] Enns R， Eloubeidi MA， Mergener K， et al. ERCP related perforations:risk factors and management. Endoscopy， 2002， 34(4):293- 298.
[19] Wu HM， Dixon E， May GR， et al. Management of perforation after endospoic retrograde holangiopancreatography (ERCP):a population basedreview. HPB， 2006， 8(5):393- 399., http://www.100md.com(杜波 王健 但杰)
[7] Singh P， Das A， Isenberg G， et al. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acutepancreatitis ? A meta-analysis of controlled trials. Gastrointest Endosc，2004，60(4):544-550.
[9] Arvanitidis D， Anagnostopoulos GK， Giannopoulos D， et al. Can somatostatin prevent post-ERCP pancreatitis ? Results of a randomized controlled trial. J Gastroenterol Hepatol，2004，19(3):278-282.
, http://www.100md.com
[9] Masci E，Cavallini G， Mariani A. Comparison of two dosing regimens of gabexate in the prophylaxis of post-ERCP pancreatitis. Am J Gastroenterol，2003，98(10):2182-2186.
[10] 宋丽亚， 赵清喜， 孔心涓， 等. ENBD 预防胆管多发结石ERCP 术后急性胰腺炎及高淀粉酶血症65例. 世界华人消化杂志， 2010，18(16):1724-1727.
[11] Das A，Singh P，Sivak MV JR，et al. Pancreatic-stent placement for prevention of post-ERCP pancreatitis:a cost-effectiveness analysis. Gastrointest Endosc，2007，65(7):960-968.
, http://www.100md.com
[12] Cennamo V，Fuccio L，Zagari RM，et al. Can early precut implementation reduce endoscopic retrograde cholangiopancreatography-related complication risk ? Meta-analysis of randomized controlled trials. Endoscopy， 2010，42(5):381-388.
[13] Petrov MS，Savides TJ. Systematic review of endoscopic ultra-sonography versus endoscopic retrograde cholangiopancreatography for suspected choledocholithiasis. Br J Surg， 2009，96(9):967-974.
[14] 马洪， 肖丽达， 张广俊， 等. 超声引导内镜在梗阻性黄疸诊治中的应用研究. 广西医科大学学报，2010，27(3):397-399.
, http://www.100md.com
[15] N i e dera u C，Po hl ma nn U,L u bke H,et a l. Prop hy l ac tica nti bi o ti c treat me nt i n t herape uti c or co mp li ca t e d di a gnostic ER CP；re sults o f a ra ndo mi ze d contr o ll e d cli ni ca l stu dy. G a st rpo mtest E ndosc，1994,40：533-537.
[16] 胡冰,周岱云,龚彪.ERCP临床诊疗图解.上海:上海科学技术出版社,2004,90:239-246.
[17] Oh HC， Lee SK， Lee TY， et al. Analysis of percutaneous transhepatic cholangioscopy related complications and the risk factors for those complications. Endoscopy， 2007， 39(8):731- 736.
[18] Enns R， Eloubeidi MA， Mergener K， et al. ERCP related perforations:risk factors and management. Endoscopy， 2002， 34(4):293- 298.
[19] Wu HM， Dixon E， May GR， et al. Management of perforation after endospoic retrograde holangiopancreatography (ERCP):a population basedreview. HPB， 2006， 8(5):393- 399., http://www.100md.com(杜波 王健 但杰)